Cardiac Imaging Articles & Analysis
-
Thoma Bravo Completes Strategic Growth Investment in Circle Cardiovascular Imaging
Thoma Bravo, a leading software investment firm, today announced the completion of its strategic growth investment in Circle Cardiovascular Imaging Inc. ("Circle CVI"), the global leader in cardiovascular imaging solutions. Circle CVI is the leading provider of AI-based cardiac imaging and reporting solutions, including cardiac MRI ("CMR") and cardiac computerized tomography ("CT") imaging ...
-
Circle Cardiovascular Imaging Announces Strategic Growth Investment from Thoma Bravo
Circle Cardiovascular Imaging Inc. ("Circle CVI"), the global leader in cardiovascular imaging solutions, today announced a strategic growth investment from Thoma Bravo, a leading software investment firm. Thoma Bravo's partnership is expected to drive future investment in product innovation, extend Circle CVI's market leadership position and fuel future growth. Financial terms of the transaction ...
-
Elucid Appoints Dr. Michael Lesh to Board of Directors
BOSTON, November 3, 2022 – Elucid, Inc., a leading medical technology company providing physicians with AI-powered imaging analysis software to characterize cardiovascular disease, today announced the addition of Michael D. Lesh, MD, FACC, to its Board of Directors. “We look forward to what Dr. Lesh will bring to the board with his extensive background as a cardiologist, medtech ...
By Elucid
-
Positron Corporation Retains FDA Consulting Firm in Preparation for 510K New Device Application
Niagara Falls, NY – February 17, 2022 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a nuclear medicine PET imaging device systems and clinical services company, is pleased to announce today that the Company has retained Medical Device Academy ”MDA”) as its consultant for the Company’s new PET/CT device 510K ...
-
William A. (Bill) Breukelman Named to CardioWise, Inc. Board of Directors
An internationally recognized entrepreneur, Mr. Breukelman is a pioneer in imaging technology, initially as principal and chairman of IMAX Corporation, followed by significant transformative contributions to medical and scientific research companies in information technology and strategic development. Jack Coats, Chief Executive Officer of CardioWise, Inc., announced that Mr. William A. ...
-
Spectrum Dynamics Receives Approval from Health Canada for VERITON-CT64 Digital SPECT/CT
Spectrum Dynamics Medical, Inc., has received Canadian Medical Device License from Health Canada for its premium digital SPECT/ 64-sliceCT scanner, VERITON-CT64. VERITON-CT64 is designed for both, total body and organ-focused, hybrid imaging with shorter scan times, at lower injected activity when compared to current analog dual-detector technology. VERITON-CT64 SPECT/CT digital technology plus ...
-
CardioWise™ Acquires Worldwide Rights to Patent, and Software to Guide Cardiac Resynchronization Therapy Through License Agreement with Johns Hopkins Technology Ventures
CardioWise, Inc., is pleased to announce that the company has acquired the worldwide rights to Image Toolbox heart functional analysis software, and pending patent from Johns Hopkins Technology Ventures through a license agreement. The US Patent application was filed November 11, 2016. The software uses cardiac CT patient data sets to determine which heart failure patients may benefit from ...
-
Finally, Digital Myocardial Perfusion Imaging That’s Within Reach: SPECT CZT Technology Just Became More Accessible
Spectrum Dynamics Medical, Inc., announced today that they have a new offering into their industry-leading D-SPECT® family with the introduction of D-SPECT® VISTA. The new addition is specifically designed as an affordable entry into digital based solid-state Cadmium Zinc Telluride (CZT) myocardial perfusion imaging (MPI) for institutions wishing to transition from an older, analog ...
-
CardioWise Completes Small Business Innovation and Research Grant from the National Science Foundation
CardioWise, Inc. has completed National Science Foundation (NSF) Phase I and IB Small Business Innovation and Research (SBIR) grants that continued the development and commercialization of a non-invasive analysis method for detection of heart disease. The final report submitted to the NSF in December detailed the research and development milestones that were achieved during the 2013 award period ...
-
Think Porthole: Challenges to imaging the heart with ultrasound
There is no doubt that 2-dimensional (2D) ultrasound imaging can be a challenging task to learn. Performing ultrasound requires some imagination. A simple turn of the transducer can change the orientation of anatomy. Therefore, learning anatomy in this way is not always straightforward as with 3-dimensional fixed images. To further complicate matters, the human body presents obstacles at nearly ...
-
GE Healthcare in collaboration with Nex Cubed select six digital health start-ups for inaugural Edison Accelerator in Canada
Six digital health start-ups from five countries have officially become the first cohort of the Edison Accelerator in Canada – a program designed by GE Healthcare and delivered in collaboration with Nex Cubed to accelerate, validate, and scale innovative solutions that address important challenges in the healthcare sector. The companies all focus on applying Artificial Intelligence (AI) to ...
-
Perma-Fix Signs Option Agreement to License Technology for Use in Proprietary Process to Produce Medical Isotopes
ATLANTA, June 3, 2011 /PRNewswire/ -- Perma-Fix Environmental Services, Inc. (NASDAQ: PESI) today announced it has signed an exclusive option agreement with Battelle, which operates Pacific Northwest National Laboratory for the U.S. Department of Energy, to license technology from PNNL for use with Perma-Fix's proprietary process to safely and cost-effectively produce Molybdenum-99 (Mo-99), which ...
-
Nanox Announces Issuance of American Medical Association New Category III CPT® Code for Its Coronary Artery Calcium Population Health Solution
NEVE ILAN, Israel--(BUSINESS WIRE)--Jan. 11, 2022-- NANO-X IMAGING LTD ("Nanox" or the "Company," Nasdaq: NNOX), an innovative medical imaging technology company, and its deep-learning medical imaging analytics subsidiary, Nanox.AI, today announced that the American Medical Association (AMA) has issued a new Category III Current Procedural Terminology (CPT) code for quantitative CT tissue ...
-
Positron Investor Update
In consideration of our announcement of the collaboration with Neusoft Medical Systems and the expansion into the PET/CT modality we are pleased to update you on key developments that set the path for the growth and success at Positron for many years to come. As many of our investors know, in 2021 Positron returned to being a full reporting company with the OTC Markets. The Company will continue ...
-
TeraRecon Announces DocPanel Signs Contract for Intuition Titanium, Reaffirming its Cardiothoracic Imaging Service Commitment
TeraRecon, a ConcertAI company and a leader in advanced medical visualization using AI to improve patient care, today announced U.S.-based DocPanel, the world’s first radiology marketplace offering access to over 500 fellowship trained radiologists available for radiological reads, second opinions, and educational consults, has signed a contract for TeraRecon’s advanced visualization ...
-
Positron Enters Long Term Cooperation Agreement with Neusoft Medical Systems
Positron Enters Long Term Cooperation Agreement with Neusoft Medical Systems for the Development and Distribution of Positron’s State of the Art PET/CT System in North America Niagara Falls, NY – January 18, 2022 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a nuclear medicine PET imaging company specializing in the field ...
-
Alnylam Presents Additional Results from the APOLLO-B Phase 3 Study of Patisiran in Patients with ATTR Amyloidosis with Cardiomyopathy at Heart Failure Society of America Annual Meeting
– New Data Further Support Potential for Patisiran to be an Effective Treatment for Cardiomyopathy of ATTR Amyloidosis – – Data from Exploratory Endpoints, Including Cardiac Biomarkers and Imaging, Suggest Favorable Impact of Patisiran on Measures of Cardiac Stress, Injury, Structure, and Function at Month 12 – – Treatment with Patisiran Demonstrated Generally ...
-
Vektor Medical receives FDA clearance for vMAP, First Technology designed to identify arrhythmia hot spots anywhere in heart in minutes using only ECG data
Vektor Medical, Inc. today announced U.S. Food and Drug Administration (FDA) 510(k) clearance for its novel computational ECG mapping system, vMap™. vMap is designed to map potential arrhythmia sources (hot spots) associated with stable or unstable arrhythmias anywhere in the heart – including all four chambers, the septal wall, and the outflow tracts – in less than three ...
-
Bayer driving innovation in radiology with new research across the portfolio presented at ECR
Featured presentations include development compound gadoquatrane, a novel contrast agent for MRI Further research explores potential of AI and digital advances in medical imaging Bayer announced today that new data from the company’s advanced radiology portfolio will be presented at the 2023 European Congress of Radiology (ECR), taking place from March 1-5 in Vienna, Austria. The ...
By Bayer AG
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you